炎症响应型一氧化氮清除及一氧化碳释放微胶囊可缓解哮喘患者的肺部炎症及Th2型细胞因子过度分泌
Inflammation-Responsive NO-Scavenging and CO-Releasing Micelles Alleviate Pulmonary Inflammation and Th2 Cytokine Production in Asthma
Rong Daoxiang, Wang Sai, Luo Yi, Zheng Haihan, Huo Shaohu, Zhu Yulin, Ding Shenggang, Zhou Rui
Journal:ACS Applied Bio Materials
IF:5.6
DOI:10.1021/acsabm.6c00590
PMID:42571630
Published:2026-08-09
research field:药物递送系统免疫学呼吸医学炎症生物学气体递质生物学纳米医学
Abstract
Asthma is a heterogeneous and complex disorder characterized by chronic airway inflammation, presenting significant therapeutic challenges. Nitric oxide (NO) and carbon monoxide (CO) serve as pivotal gaseous signaling molecules, with elevated NO levels linked to disease exacerbation, while low-dose CO exerts anti-inflammatory effects. In this study, we engineered a dual gas-regulating micelle (DGRM) nanoplatform capable of simultaneously scavenging NO and releasing CO. In an LPS-stimulated macrophage inflammation model, DGRM demonstrated excellent biocompatibility, effectively eliminated NO and reactive oxygen species (ROS), and markedly inhibited the production of pro-inflammatory cytokines (IL-6 and IFN-γ). Furthermore, in an ovalbumin (OVA)-induced allergic asthma murine model, nebulized DGRM administration exhibited pronounced therapeutic effects. Mechanistic investigations revealed that DGRM downregulated inducible nitric oxide synthase (iNOS) while upregulating heme oxygenase-1 (HO-1), thereby modulating the iNOS/HO-1/CO signaling axis. These findings collectively indicate that DGRM effectively mitigates airway inflammation in allergic asthma, offering a gasotransmitter-based nanotherapeutic approach for asthma management.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


